Doxazosin Sandoz

Extended-release tablets for high blood pressure and enlarged prostate (BPH)

Rx – Prescription Only Alpha-1 Blocker
Active Ingredient
Doxazosin (as mesilate)
Dosage Form
Extended-release tablet
Strength
4 mg
Manufacturer
Sandoz
Medically reviewed | Last reviewed: | Evidence level: 1A
Doxazosin Sandoz contains the active ingredient doxazosin, a selective alpha-1 adrenergic blocker available as an extended-release (modified-release) tablet. It is prescribed for two distinct conditions: the management of high blood pressure (hypertension) and the relief of urinary symptoms caused by an enlarged prostate gland (benign prostatic hyperplasia, or BPH) in men. By relaxing smooth muscle in blood vessels and the prostate, doxazosin helps lower blood pressure and improve urinary flow.
Published:
Reading time: 14 minutes
Reviewed by iMedic Medical Editorial Team | Specialists in clinical pharmacology

Quick Facts About Doxazosin Sandoz

Active Ingredient
Doxazosin
(as mesilate)
Drug Class
Alpha-1 Blocker
Selective antagonist
Common Uses
Hypertension & BPH
Blood pressure & prostate
Available Forms
ER Tablet
Extended-release 4 mg
Prescription Status
Rx Only
Prescription required
Standard Dose
4–8 mg/day
Once daily

Key Takeaways About Doxazosin Sandoz

  • Dual therapeutic action: Doxazosin Sandoz treats both high blood pressure and symptoms of enlarged prostate (BPH) by relaxing smooth muscle in blood vessels and the prostate gland
  • Extended-release formulation: The tablet releases medication gradually over 24 hours – it must be swallowed whole, never chewed, crushed, or split
  • Watch for first-dose dizziness: Orthostatic hypotension (dizziness when standing) can occur, especially at the start of treatment – stand up slowly and avoid sudden position changes
  • Inform your eye surgeon: If you are scheduled for cataract surgery, tell your ophthalmologist that you take or have taken doxazosin, as it can cause intraoperative floppy iris syndrome (IFIS)
  • Be cautious with ED medications: Doxazosin combined with PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) can cause significant blood pressure drops – always consult your doctor first

What Is Doxazosin Sandoz and What Is It Used For?

Doxazosin Sandoz is an alpha-1 adrenergic blocker used to treat high blood pressure (hypertension) and urinary symptoms from an enlarged prostate gland (benign prostatic hyperplasia, or BPH). The extended-release tablet delivers doxazosin gradually over 24 hours, allowing once-daily dosing with a smoother blood pressure profile.

Doxazosin belongs to a class of medications known as alpha-adrenergic blockers, sometimes simply called alpha-blockers. These drugs work by selectively blocking alpha-1 adrenergic receptors, which are found on the smooth muscle cells lining blood vessels and in the prostate gland. The Sandoz formulation is specifically designed as an extended-release (modified-release) tablet, meaning the active ingredient is released slowly and continuously from the tablet matrix as it passes through the gastrointestinal tract.

In patients with high blood pressure (hypertension), doxazosin works by causing the blood vessels to relax and widen, which reduces the resistance to blood flow. This mechanism directly lowers blood pressure. Hypertension is a major risk factor for cardiovascular disease, stroke, and kidney disease, and effective long-term blood pressure control is essential for preventing these complications. Clinical trials have demonstrated that doxazosin effectively lowers both systolic and diastolic blood pressure when taken regularly.

In men with benign prostatic hyperplasia (BPH), the prostate gland becomes enlarged and can compress the urethra, leading to troublesome urinary symptoms. These symptoms include a weak urinary stream, difficulty starting urination, frequent urination (especially at night), and a feeling of incomplete bladder emptying. Doxazosin relaxes the smooth muscle in and around the prostate gland and bladder neck, allowing urine to flow more freely. This provides relief from the bothersome lower urinary tract symptoms (LUTS) associated with BPH.

The extended-release formulation offers certain advantages over immediate-release doxazosin tablets. Because the drug is released gradually, there are fewer peaks and troughs in blood levels throughout the day. This typically results in a more consistent therapeutic effect and may reduce the incidence of side effects, particularly the dizziness associated with rapid drops in blood pressure after taking the medication.

Important: Empty tablet shells in stool

Doxazosin Sandoz extended-release tablets use a special non-absorbable shell that controls the release of the medication. After the drug has been fully released, the empty shell passes through the digestive system and may be visible in your stool. This is completely normal and does not mean the medication has not been absorbed properly.

What Should You Know Before Taking Doxazosin Sandoz?

Before starting Doxazosin Sandoz, your doctor needs to know about any liver disease, heart conditions, planned eye surgeries, or if you are pregnant. There are important contraindications and drug interactions that must be evaluated to ensure your safety during treatment.

Contraindications

You must not take Doxazosin Sandoz if any of the following conditions apply to you:

  • Allergy to doxazosin or related quinazolines: If you have a known hypersensitivity to doxazosin, or to related alpha-blockers such as prazosin or terazosin, or to any of the inactive ingredients in the tablet
  • Gastrointestinal obstruction: If you have any narrowing or blockage in the gastrointestinal tract, because the extended-release tablet could become lodged and cause a blockage
  • Urinary tract obstruction with BPH: If you have an enlarged prostate together with obstruction of the upper urinary tract, chronic urinary tract infections, or bladder stones
  • Overflow incontinence or anuria: If you are unable to urinate (anuria), have overflow incontinence, or have kidney failure
  • Low blood pressure with BPH treatment: If you are being treated for enlarged prostate and already have low blood pressure (hypotension)
  • History of orthostatic hypotension: If you have experienced, or have a history of, blood pressure drops upon standing that have caused dizziness, lightheadedness, or fainting

Warnings and Precautions

Discuss the following with your doctor before starting treatment:

  • Liver disease: If you have any liver problems, your doctor will need to monitor you closely during treatment. Doxazosin Sandoz is not recommended for patients with severe liver impairment, as the drug is extensively metabolized in the liver
  • Heart disease: If you have any cardiac condition, particularly heart failure or pulmonary edema (fluid accumulation in the lungs), your doctor must carefully weigh the risks and benefits before prescribing doxazosin
  • Cataract surgery: If you are scheduled for or considering cataract surgery, it is crucial to inform your ophthalmologist that you are taking or have previously taken doxazosin. A condition called intraoperative floppy iris syndrome (IFIS) has been observed during cataract surgery in patients treated with alpha-blockers. This can make the surgical procedure more complex
  • Postural hypotension: Dizziness, weakness, and in rare cases fainting can occur, particularly when you first start taking doxazosin or when the dose is increased. Be especially careful when getting up from a lying or sitting position. If you feel dizzy or lightheaded, lie down immediately until the symptoms pass
Seek immediate medical attention

In very rare cases, doxazosin may cause priapism – a prolonged and sometimes painful erection lasting several hours. This is a medical emergency that requires immediate treatment to prevent permanent damage. Contact a doctor or go to the emergency department immediately if this occurs.

Pregnancy and Breastfeeding

The safety of doxazosin during pregnancy has not been adequately established in clinical studies. If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before taking this medication. Your doctor will assess whether the potential benefits outweigh the risks to the developing baby.

Small amounts of doxazosin may pass into breast milk. If you are breastfeeding, you should not take Doxazosin Sandoz unless specifically advised to do so by your doctor. Alternative medications that are better studied in breastfeeding may be available for your condition.

Driving and Operating Machinery

Doxazosin Sandoz can affect your ability to drive or operate machinery safely, particularly at the start of treatment. The medication may cause dizziness, weakness, or drowsiness. If you experience these symptoms, do not drive, operate machinery, or perform any activities that require alertness until you know how the medication affects you. The risk of these effects is highest during the first few days of treatment and when the dose is increased.

Sodium Content

This medicine contains less than 1 mmol sodium (23 mg) per tablet, meaning it is essentially sodium-free. This is relevant for patients on a controlled sodium diet.

How Does Doxazosin Sandoz Interact with Other Drugs?

Doxazosin Sandoz can interact with several other medications, most notably PDE-5 inhibitors for erectile dysfunction (sildenafil, tadalafil, vardenafil), other blood pressure medications, and certain antifungal and antiviral drugs. These interactions can increase the risk of dangerously low blood pressure or enhance side effects.

Drug interactions are an important consideration with any medication, and doxazosin is no exception. Because doxazosin lowers blood pressure by relaxing blood vessels, combining it with other medications that also lower blood pressure can lead to an additive effect, potentially causing symptoms of hypotension such as dizziness, lightheadedness, or fainting. Always inform your doctor about all medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements.

Major Interactions

Significant Drug Interactions with Doxazosin Sandoz
Drug / Drug Class Interaction Effect Clinical Advice
PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) Additive blood pressure lowering; risk of symptomatic hypotension including dizziness, lightheadedness, and fainting Stabilize on doxazosin before starting PDE-5 inhibitor. Start with lowest dose of PDE-5 inhibitor. Take at least 6 hours apart.
Other antihypertensives (ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, diuretics) Enhanced blood pressure lowering effect; increased risk of hypotension Monitor blood pressure closely. Dose adjustments may be needed. Report any dizziness or lightheadedness.
Strong CYP3A4 inhibitors (ketoconazole, itraconazole, voriconazole, clarithromycin, telithromycin) May increase doxazosin blood levels, enhancing both therapeutic and adverse effects Use with caution. Your doctor may need to reduce the doxazosin dose or monitor you more closely.
HIV protease inhibitors (ritonavir, indinavir, nelfinavir, saquinavir) May significantly increase doxazosin levels through CYP3A4 inhibition Close monitoring required. Dose adjustment of doxazosin may be necessary.
Nefazodone (antidepressant) CYP3A4 inhibition may increase doxazosin exposure Monitor for increased doxazosin side effects. Inform your doctor if you experience dizziness or low blood pressure.

Minor Interactions

Doxazosin may also interact with non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen. NSAIDs can reduce the blood-pressure-lowering effect of doxazosin by promoting sodium and water retention. If you regularly take NSAIDs, your doctor may need to monitor your blood pressure more frequently and consider adjusting your doxazosin dose.

Alcohol can enhance the blood-pressure-lowering effect of doxazosin, increasing the risk of dizziness and lightheadedness. It is advisable to limit alcohol consumption while taking this medication, especially during the initial weeks of treatment.

What Is the Correct Dosage of Doxazosin Sandoz?

The recommended starting dose of Doxazosin Sandoz is 4 mg once daily for both hypertension and BPH. Your doctor may increase the dose to a maximum of 8 mg once daily if needed. The extended-release tablets must be swallowed whole – never chewed, crushed, or split.

Adults (Including Elderly Patients)

The standard dose for adults is 4 mg once daily, taken as a single dose. This applies to both indications – high blood pressure and BPH symptoms. Depending on your response to treatment and tolerability, your doctor may increase the dose to 8 mg once daily, which is the maximum recommended dose for the extended-release formulation.

Dosage Guide for Doxazosin Sandoz Extended-Release Tablets
Patient Group Starting Dose Maximum Dose Special Considerations
Adults – Hypertension 4 mg once daily 8 mg once daily Monitor blood pressure regularly; dose increase after adequate assessment period
Adults – BPH 4 mg once daily 8 mg once daily Prostate cancer should be ruled out before starting treatment
Elderly patients 4 mg once daily 8 mg once daily No specific dose adjustment required; monitor for orthostatic hypotension
Liver impairment 4 mg once daily Use with caution Close monitoring required; not recommended in severe liver disease

How to Take the Tablet

  • Swallow the tablet whole with a glass of water
  • Do not chew, crush, or split the tablet – this would destroy the controlled-release mechanism
  • The tablet can be taken with or without food
  • Take at approximately the same time each day for consistent blood levels

Children and Adolescents

Doxazosin Sandoz is not recommended for use in patients under 18 years of age. The safety and efficacy of doxazosin have not been established in the pediatric population, and there is no approved indication for children or adolescents. If a young person requires treatment for hypertension, their doctor will prescribe a medication that has been specifically studied and approved for use in this age group.

Missed Dose

If you forget to take your daily dose, skip the missed dose entirely and take your next dose at the usual scheduled time. Do not take a double dose to compensate for the one you missed. Taking a double dose increases the risk of side effects, particularly a significant drop in blood pressure. If you frequently forget to take your medication, consider setting a daily reminder or alarm to help you maintain a consistent dosing schedule.

Overdose

Taking too many Doxazosin Sandoz tablets can be dangerous and may cause a severe drop in blood pressure. Symptoms of overdose may include extreme dizziness, fainting, rapid heartbeat, or loss of consciousness. If you suspect an overdose, contact a doctor, emergency services, or your local poison control center immediately. Do not wait for symptoms to develop. Keep the medication packaging to show the healthcare provider what was taken.

Do not stop suddenly

It is important to continue taking Doxazosin Sandoz as prescribed. Do not change your dose or stop taking the tablets without consulting your doctor first. Abrupt discontinuation may lead to a rebound increase in blood pressure. If you need to stop the medication, your doctor will advise you on how to do so safely.

What Are the Side Effects of Doxazosin Sandoz?

Like all medicines, Doxazosin Sandoz can cause side effects, though not everyone gets them. The most common side effects are dizziness, headache, drowsiness, fatigue, and swelling of the extremities. Serious but rare side effects include severe allergic reactions, heart problems, and liver dysfunction.

Side effects are categorized below by how frequently they occur. If you experience any side effects, particularly those listed as serious, consult your doctor or pharmacist. The frequency categories follow international medical convention:

Stop taking Doxazosin Sandoz and seek immediate medical attention if you experience:
  • Severe allergic reaction: wheezing, difficulty breathing, swelling of the face or throat, severe skin rash with red spots or blisters
  • Chest pain, increasing or irregular heartbeat, signs of heart attack or stroke
  • Yellowing of the skin or eyes, itching, loss of appetite, and dark urine (signs of liver problems)
  • Unusual bruising or bleeding (signs of decreased blood platelets)
  • Persistent, painful erection (priapism)

Common Side Effects

May affect up to 1 in 10 people

  • Dizziness, headache, drowsiness
  • Palpitations (awareness of heartbeat)
  • Low blood pressure; blood pressure drop when standing (orthostatic hypotension) leading to dizziness or lightheadedness
  • Vertigo (spinning sensation)
  • Respiratory and urinary tract infections
  • Shortness of breath, nasal congestion or runny nose, bronchitis, cough
  • Abdominal pain, indigestion, dry mouth, nausea
  • Itching
  • Back pain, muscle pain
  • Painful or frequent urination, urinary incontinence
  • Fatigue, weakness, chest discomfort, flu-like symptoms
  • Swelling of hands, ankles, or feet (edema)

Uncommon Side Effects

May affect up to 1 in 100 people

  • Loss of appetite or increased appetite
  • Gout (joint pain and swelling)
  • Anxiety, depression, difficulty sleeping
  • Decreased skin sensitivity, fainting, tremor
  • Ringing in the ears (tinnitus)
  • Nosebleeds
  • Constipation, diarrhea, flatulence, vomiting, gastroenteritis
  • Abnormal liver function test results
  • Skin rash
  • Joint pain
  • Blood in urine, difficulty or painful urination
  • Erectile dysfunction
  • Pain, facial swelling
  • Weight gain

Rare Side Effects

May affect up to 1 in 1,000 people

  • Gastrointestinal obstruction (blocked intestine)

Very Rare Side Effects

May affect up to 1 in 10,000 people

  • Low white blood cell count (leukopenia)
  • Agitation, nervousness, tingling or numbness in hands and feet
  • Blurred vision
  • Slow heart rate (bradycardia)
  • Hot flushes, difficulty breathing or wheezing
  • Hair loss, purplish skin patches (purpura), itchy rash (urticaria)
  • Muscle cramps, muscle weakness
  • Urinary urgency, increased need to urinate at night (nocturia)
  • Breast enlargement in men (gynecomastia)
  • Fatigue, general feeling of being unwell (malaise)

Frequency Not Known

Reported from post-marketing experience

  • Retrograde ejaculation (semen enters the bladder instead of exiting through the urethra, resulting in a “dry orgasm”)
  • Intraoperative floppy iris syndrome (IFIS) – a complication that may occur during cataract surgery
Reporting Side Effects

It is important to report suspected side effects after a medicine has been authorized. This helps to continuously monitor the benefit-risk balance of the medicine. You can report side effects to your national medicines regulatory authority or directly to your healthcare provider.

How Should You Store Doxazosin Sandoz?

Store Doxazosin Sandoz at room temperature, away from moisture and direct sunlight. Keep the tablets in their original packaging until use. Keep all medicines out of the reach and sight of children.

There are no special storage conditions required for Doxazosin Sandoz. Store the tablets at normal room temperature (below 25°C / 77°F) in the original blister packaging to protect them from moisture. Do not use the tablets after the expiry date printed on the blister pack and the outer carton. The expiry date refers to the last day of the indicated month.

Do not dispose of medicines in household waste or via the sewage system. Ask your pharmacist about how to properly dispose of medications that are no longer needed. These measures help to protect the environment and prevent accidental exposure.

What Does Doxazosin Sandoz Contain?

Each Doxazosin Sandoz extended-release tablet contains 4 mg of doxazosin (as mesilate) as the active ingredient, along with inactive excipients that form the controlled-release matrix. The tablets are white, round, biconvex, and engraved with “DL”.

Active substance: Each tablet contains 4 mg doxazosin (as doxazosin mesilate). Doxazosin mesilate is the salt form that is used in the tablet formulation, and the stated strength refers to the amount of doxazosin base – the pharmacologically active component.

Inactive ingredients (excipients): Macrogol 200, macrogol 900, butylated hydroxytoluene (E321), microcrystalline cellulose, povidone K30, all-rac-alpha-tocopherol (E307), colloidal anhydrous silicon dioxide, sodium lauryl fumarate, methacrylic acid – ethyl acrylate copolymer (1:1) dispersion 30%, colloidal hydrated silicon dioxide, macrogol (1300–1600), and titanium dioxide (E171).

Appearance: White, round, biconvex tablets engraved with “DL”. Available in blister packs (PVC/PVDC/aluminium) of 14, 28, 30, 56, 98, or 100 tablets.

Frequently Asked Questions About Doxazosin Sandoz

Medical References & Sources

All medical information is based on peer-reviewed research and international guidelines. Evidence Level 1A.

  1. European Medicines Agency (EMA). Doxazosin – Summary of Product Characteristics (SmPC). European public assessment reports. Available at: ema.europa.eu
  2. British National Formulary (BNF). Doxazosin – Indications, dosage, interactions, and side effects. National Institute for Health and Care Excellence. Available at: bnf.nice.org.uk
  3. U.S. Food and Drug Administration (FDA). Cardura XL (doxazosin mesylate) – Prescribing Information. FDA Drug Approvals and Databases. Available at: fda.gov
  4. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List (2023). Cardiovascular medicines: anti-hypertensives. Geneva: World Health Organization.
  5. ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The ALLHAT trial. JAMA. 2002;288(23):2981-2997. doi:10.1001/jama.288.23.2981
  6. McConnell JD, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387-2398. doi:10.1056/NEJMoa030656
  7. National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management (NG136). Updated 2022. Available at: nice.org.uk/guidance/ng136
  8. European Association of Urology (EAU). Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). 2024 Edition.

iMedic Medical Editorial Team

This article has been written and reviewed by our team of specialist physicians.

Clinical Pharmacology

Specialist physicians in clinical pharmacology with expertise in drug mechanisms, interactions, and evidence-based prescribing.

Internal Medicine & Cardiology

Board-certified internists and cardiologists experienced in hypertension management and cardiovascular pharmacotherapy.

Urology

Specialist urologists with clinical expertise in the management of benign prostatic hyperplasia and lower urinary tract symptoms.

Medical Review Board

Independent panel of medical experts who peer-review all content according to GRADE evidence framework and international guidelines.

iMedic Editorial Standards

Peer Review Process

All medical content is reviewed by at least two licensed specialist physicians before publication.

Fact-Checking

All medical claims are verified against peer-reviewed sources and international guidelines.

Update Frequency

Content is reviewed and updated at least every 12 months or when new research emerges.

Corrections Policy

Any errors are corrected immediately with transparent changelog.

Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in clinical pharmacology, internal medicine, cardiology, urology, and other relevant specialties.